Abstract
The purpose of this study was to explore methods of selectively enriching CD34 + haematopoietic progenitor cells (HPC) in mononuclear cell (MNC) preparations, and to outline a procedure for cryopreservation and thawing of manufactured material. Density gradient centrifugation of umbilical cord blood was achieved using Ficoll-Paque™ media at 1.077 g/mL and 1.065 g/mL densities and Leucosep preparation tubes. Post-process samples were analysed for CD34 + and MNC content. Finally, MNCs were frozen down at a concentration of 8.5 × 106 cells/mL in CryoStor CS10 using an Asymptote VIAFreeze controlled rate freezer at a rate of − 2 °C per minute, then thawed and analysed for viability and recovery. Processing with 1.065 g/mL media selectively depleted non-HPC cell types, producing an approximately fourfold increase in CD34 + frequency (M ± 1SD = 1.4 ± 1.3%, P < 0.01) relative to the pre-process sample (M ± 1SD = 0.4 ± 0.3%), whereas 1.077 g/mL media produced only a twofold enrichment (0.7 ± 0.6, P < 0.01). This was not accompanied by any significant forfeit of CD34 + recovery (79 ± 32% vs. 78 ± 32% respectively; P = 0.87). The MNCs generated by the 1.065 g/mL procedure were of greater purity (96 ± 2%) than in the 1.077 g/mL procedure (80 ± 7%, P < 0.01). Post-thaw, MNC viability was 95 ± 1% and CD34 + viability was 98 ± 1%. Ultra-pure MNCs rich in CD34 + HPCs can be generated with a simple, inexpensive modification to Ficoll-Paque™ media. These products can be easily cryopreserved using a simple controlled rate freezing procedure.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
European Commission (2017) EudraLex: the rules governing medicinal products in the European Union-volume 4: good manufacturing practice, Brussels: European Commission.
Jungebluth P et al (2015) Autologous peripheral blood mononuclear cells as treatment in refractory acute respiratory distress syndrome. Respiration 90(6):481–492
Kaur I et al (2017) Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: the automated Sepax system versus the manual Ficoll method. Cytotherapy 19(3):433–439
Mosallaei et al. (2019) PBMCs: a new source of diagnostic and prognostic biomarkers. J Metab Dis
Riedhammer C et al (2016) Peripheral blood mononuclear cells: isolation, freezing, thawing, and culture. Methods Mol Biol 1304:53–61
Scaradavou A et al (2015) Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transpl 16(4):500–508
Zhang S et al (2017) A simple method for removing low-density granulocytes to purify T lymphocytes from peripheral blood mononuclear cells. J Zhejiang Univ Sci B 18(7):605–614
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
Conception and design of the study: LW, CL. Acquisition of data: LW. Analysis and interpretation of data: LW. Drafting or revising the manuscript: LW, CL, MGW.
Corresponding author
Ethics declarations
Competing interest
The authors have no commercial, proprietary or financial interest in the products or companies described in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wynn, L., Wilson, M.G. & Leonforte, C. Manufacturing of CD34 + HPC-enriched, high-purity mononuclear cell products from umbilical cord blood. Cell Tissue Bank 24, 685–691 (2023). https://doi.org/10.1007/s10561-023-10070-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-023-10070-8